Potential drug development candidates for human soil-transmitted helminthiases

PLoS Neglected Tropical Diseases

Volumn 5, Issue 6, 2011, Pages

  Olliaro, Piero ^a   Seiler, Jürg ^b   Kuesel, Annette ^a   Horton, John ^c   Clark, Jeffrey N ^d   Don, Robert ^e   Keiser, Jennifer ^f,g  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ToxiConSeil ^*  (Switzerland)

^c Tropical Projects   (United Kingdom)

^d JNC Consulting Services LLC   (United States)

^e Drugs for Neglected Diseases Initiative DNDi   (Switzerland)

^f SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^g UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AMIDANTEL; BITHIONOL; CLORSULON; CLOSANTEL; DERQUANTEL; EMODEPSIDE; FEBANTEL; FENBENDAZOLE; FLUBENDAZOLE; IVERMECTIN; LEVAMISOLE; MONEPANTEL; NITAZOXANIDE; NITROSCANATE; NITROXINIL; OXFENDAZOLE; PARAHERQUAMIDE; PARAHERQUAMIDE A; PIPERAZINE; PRAZIQUANTEL; PYRANTEL EMBONATE; RAFOXANIDE; UNCLASSIFIED DRUG; AMINOACETONITRILE; ANTHELMINTIC AGENT; DEPSIPEPTIDE; DRUG DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL PARASITOSIS; ANTHELMINTIC ACTIVITY; ARTICLE; ASCARIASIS; ASCARIDIASIS; CESTODIASIS; CRYPTOSPORIDIOSIS; DOSE RESPONSE; DRUG APPROVAL; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; FILARIASIS; GASTROINTESTINAL INFECTION; GIARDIASIS; HELMINTHIASIS; HOOKWORM INFECTION; HUMAN; MEDICAL DECISION MAKING; NEMATODIASIS; NONHUMAN; PARASITE TRANSMISSION; PROCESS DEVELOPMENT; REPRODUCTIVE TOXICITY; RISK REDUCTION; SINGLE DRUG DOSE; SOIL ORGANISM; TREMATODIASIS; TRICHURIASIS; VETERINARY MEDICINE; ANIMAL; DRUG SCREENING; EUROPE; METHODOLOGY; UNITED STATES;

AMINOACETONITRILE; ANIMALS; ANTHELMINTICS; DEPSIPEPTIDES; DRUG APPROVAL; DRUG EVALUATION, PRECLINICAL; EUROPE; HELMINTHIASIS; HELMINTHIASIS, ANIMAL; HUMANS; THIAZOLES; UNITED STATES;

EID: 79959858223     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001138     Document Type: Article

References (52)

1. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, et al. (2006) Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367: 1521-1532.
2. Chan MS, (1997) The global burden of intestinal nematode infections-fifty years on. Parasitol Today 13: 438-443.
3. de Silva N, Brooker S, Hotez PJ, Montresor A, Engels D, et al. (2003) Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 19: 547-551.
4. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
5. Brooker S, (2010) Estimating the global distribution and disease burden of intestinal nematode infections: adding up the numbers-a review. Int J Parasitol 40: 1137-1144.
6. WHO (2006) Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. World Health Organization, Geneva.
7. Keiser J, Utzinger J, (2010) The drugs we have and the drugs we need against major helminth infections. Adv Parasitol 73: 197-230.
8. Keiser J, Utzinger J, (2008) Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. Jama 299: 1937-1948.
9. Geerts S, Gryseels B, (2000) Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev 13: 207-222.
10. Kaplan RM, (2004) Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol 20: 477-481.
11. Dickson M, Gagnon JP, (2004) Key factors in the rising cost of new drug discovery and development. Nat Rev Drug Discov 3: 417-429.
12. Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, et al. (2010) Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 40: 1-13.
13. Wood IB, Amaral NK, Bairden K, Duncan JL, Kassai T, et al. (1995) World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine). Vet Parasitol 58: 181-213.
14. Gutman J, Emukah E, Okpala N, Okoro C, Obasi A, et al. (2010) Effects of annual mass treatment with ivermectin for onchocerciasis on the prevalence of intestinal helminths. Am J Trop Med Hyg 83: 534-541.
15. Wen LY, Yan XL, Sun FH, Fang YY, Yang MJ, et al. (2008) A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China. Acta Trop 106: 190-194.
16. Catton DG, Van Schalkwyk PC, (2003) The efficacy of two anthelmintics against ascarids and hookworms in naturally infected cats. Parasitol Res 90 (Suppl 3): S144-145.
17. Reichard MV, Wolf RF, Carey DW, Garrett JJ, Briscoe HA, (2007) Efficacy of fenbendazole and milbemycin oxime for treating baboons (Papio cynocephalus anubis) infected with Trichuris trichiura. J Am Assoc Lab Anim Sci 46: 42-45.
18. Lacey E, (1988) The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int J Parasitol 18: 885-936.
19. Lacey E, Gill JH, (1994) Biochemistry of benzimidazole resistance. Acta Trop 56: 245-262.
20. Rim HJ, Lee JS, Joo KH, Kim YS, (1981) Anthelmintic effects of single doses of fenbendazole and oxantel-pyrantel pamoate to the intestinal nematodes. Kisaengchunghak Chapchi 19: 95-100.
21. Yamazaki M, Okuvama E, (1981) The structure of paraherquamide, a toxid metabolite from Penicillum Paraherquei. Tetrahedron Letters 22: 135-136.
22. Blizzard TA, Margiatto G, Mrozik H, Schaeffer JM, Fisher MH, (1991) Chemical modification of paraherquamide. 4. 1-N-substituted analogs. Tetrahedron Lett 32: 2441-2444.
23. Shoop WL, Michael BF, Haines HW, Eary CH, (1992) Anthelmintic activity of paraherquamide in calves. Vet Parasitol 43: 259-263.
24. Zinser EW, Wolf ML, Alexander-Bowman SJ, Thomas EM, Davis JP, et al. (2002) Anthelmintic paraherquamides are cholinergic antagonists in gastrointestinal nematodes and mammals. J Vet Pharmacol Ther 25: 241-250.
25. Shoop WL, Eary CH, Michael BF, Haines HW, Seward RL, (1991) Anthelmintic activity of paraherquamide in dogs. Vet Parasitol 40: 339-341.
26. Lee BH, Clothier MF, Dutton FE, Nelson SJ, Johnson SS, et al. (2002) Marcfortine and paraherquamide class of anthelmintics: discovery of PNU-141962. Curr Top Med Chem 2: 779-793.
27. European Medicines Agency. Committee for Medicinal Products for Veterinary Use (2010) European public MRL assessment report (EPMAR). Derquantel (ovine species).
28. Little PR, Hodges A, Watson TG, Seed JA, Maeder SJ, (2010) Field efficacy and safety of an oral formulation of the novel combination anthelmintic, derquantel-abamectin, in sheep in New Zealand. N Z Vet J 58: 121-129.
29. Urbani C, Albonico M, (2003) Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns. Acta Trop 86: 215-221.
30. Thomas H, (1979) The efficacy of amidantel, a new anthelmintic, on hookworms and ascarids in dogs. Tropenmed Parasitol 30: 404-408.
31. Tomlinson G, Albuquerque CA, Woods RA, (1985) The effects of amidantel (BAY d 8815) and its deacylated derivative (BAY d 9216) on Caenorhabditis elegans. Eur J Pharmacol 113: 255-262.
32. Harder A, (2002) Milestones of helmintic research at Bayer. Parasitol Res 88: 477-480.
33. Xiao SH, Wu HM, Tanner M, Utzinger J, Chong W, (2005) Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 94: 1-14.
34. Keiser J, Utzinger J, (2007) Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends Parasitol 23: 555-562.
35. Elitok B, Elitok OM, Kabu M, (2006) Field trial on comparative efficacy of four fasciolicides against natural liver fluke infection in cattle. Vet Parasitol 135: 279-285.
36. Sasaki T, Takagi M, Yaguchi T, Miyadoh S, Okada T, et al. (1992) A new anthelmintic cyclodepsipeptide, PF1022A. J Antibiot (Tokyo) 45: 692-697.
37. Harder A, von Samson-Himmelstjerna G, (2002) Cyclooctadepsipeptides-a new class of anthelmintically active compounds. Parasitol Res 88: 481-488.
38. von Samson-Himmelstjerna G, Harder A, Sangster NC, Coles GC, (2005) Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle. Parasitology 130: 343-347.
39. Harder A, Schmitt-Wrede HP, Krucken J, Marinovski P, Wunderlich F, et al. (2003) Cyclooctadepsipeptides- an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents 22: 318-331.
40. Guest M, Bull K, Walker RJ, Amliwala K, O'Connor V, et al. (2007) The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans. Int J Parasitol 37: 1577-1588.
41. von Samson-Himmelstjerna G, Harder A, Schnieder T, Kalbe J, Mencke N, (2000) In vivo activities of the new anthelmintic depsipeptide PF 1022A. Parasitol Res 86: 194-199.
42. Ducray P, Gauvry N, Pautrat F, Goebel T, Fruechtel J, et al. (2008) Discovery of amino-acetonitrile derivatives, a new class of synthetic anthelmintic compounds. Bioorg Med Chem Lett 18: 2935-2938.
43. Kaminsky R, Ducray P, Jung M, Clover R, Rufener L, et al. (2008) A new class of anthelmintics effective against drug-resistant nematodes. Nature 452: 176-180.
44. Rufener L, Keiser J, Kaminsky R, Mäser P, Nilsson D, (2010) Phylogenomics of Ligand-Gated Ion Channels Predicts Monepantel Effect. PLoS Pathog 6: e1001091.
45. Hosking BC, Griffiths TM, Woodgate RG, Besier RB, Le Feuvre AS, et al. (2009) Clinical field study to evaluate the efficacy and safety of the amino-acetonitrile derivative, monepantel, compared with registered anthelmintics against gastrointestinal nematodes of sheep in Australia. Aust Vet J 87: 455-462.
46. Malikides N, Spencer K, Mahoney R, Baker K, Vanhoff K, et al. (2009) Safety of an amino-acetonitrile derivative (AAD), monepantel, in ewes and their offspring following repeated oral administration. N Z Vet J 57: 193-202.
47. Kaminsky R, Gauvry N, Schorderet Weber S, Skripsky T, Bouvier J, et al. (2008) Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidate. Parasitol Res 103: 931-939.
48. Romero Cabello R, Guerrero LR, Munoz Garcia MR, Geyne Cruz A, (1997) Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg 91: 701-703.
49. Juan JO, Lopez Chegne N, Gargala G, Favennec L, (2002) Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans R Soc Trop Med Hyg 96: 193-196.
50. Diaz E, Mondragon J, Ramirez E, Bernal R, (2003) Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 68: 384-385.
51. Knopp S, Mohammed KA, Speich B, Hattendorf J, Khamis IS, et al. (2010) Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial. Clin Infect Dis 51: 1420-1428.
52. Cohen J, Dibner MS, Wilson A, (2010) Development of and access to products for neglected diseases. PLoS One 5: e10610.